Cardivas 3.125 Tablet
By Cardivas
Rx
15 Tablet in a Strip

Composition
Carvedilol(3.125mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
May, 2027

liver
When using Cardivas 3.125 Tablet, it is important to be cautious if you have liver disease. Dose adjustment of this tablet may be necessary in such cases, so make sure to consult your doctor before taking it. It is not advised to use Cardivas 3.125 Tablet if you have severe liver disease. Always prioritize your liver health and seek medical advice if needed.

kidney
Cardivas 3.125 Tablet is safe for use in patients with kidney disease. No dose adjustment is needed, but inform your doctor if you have kidney issues. Regular blood pressure monitoring is advised for potential dose adjustments.

alcohol
It is not safe to consume alcohol along with Cardivas 3.125 Tablet as it may have adverse effects.

driving
Cardivas 3.125 Tablet may reduce alertness, cause vision issues, or induce drowsiness. Avoid driving if you experience these effects.

pregnancy
Cardivas 3.125 Tablet may not be safe during pregnancy as animal studies have shown potential harm to the developing baby. Your doctor will consider the benefits and risks before prescribing it to you. Please consult your doctor before use.

breastfeeding
Cardivas 3.125 Tablet is considered safe for breastfeeding mothers. Existing data indicates no significant risk to infants, making it a likely option for nursing mothers.
| Habit Forming | No |
| Chemical Class | Carbazole & propanol derivative |
| Therapeutic Class | CARDIAC |
| Action Class | Alpha & beta blocker |
₹66.3
₹78
15% OFF
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024
